CRIS Current Research Information System

BAIARDI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.667
NA - Nord America 4.479
EU - Europa 2.963
SA - Sud America 350
AF - Africa 192
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.386
SG - Singapore 1.626
VN - Vietnam 1.397
CN - Cina 1.356
IT - Italia 1.022
HK - Hong Kong 414
GB - Regno Unito 391
DE - Germania 324
KR - Corea 244
SE - Svezia 236
BR - Brasile 228
FR - Francia 188
IN - India 182
NL - Olanda 178
RU - Federazione Russa 122
FI - Finlandia 113
IE - Irlanda 112
JP - Giappone 100
ID - Indonesia 60
SC - Seychelles 56
AR - Argentina 46
CA - Canada 45
ZA - Sudafrica 45
CI - Costa d'Avorio 43
BG - Bulgaria 42
TR - Turchia 35
UA - Ucraina 35
MX - Messico 33
TH - Thailandia 30
DK - Danimarca 29
IQ - Iraq 29
JO - Giordania 29
PH - Filippine 29
AT - Austria 27
BD - Bangladesh 26
EC - Ecuador 25
ES - Italia 24
EE - Estonia 22
PL - Polonia 21
TW - Taiwan 19
PK - Pakistan 18
CH - Svizzera 15
CO - Colombia 15
BE - Belgio 14
VE - Venezuela 14
SA - Arabia Saudita 11
UZ - Uzbekistan 11
IL - Israele 9
CL - Cile 8
MA - Marocco 8
AU - Australia 7
MY - Malesia 7
TG - Togo 7
GR - Grecia 6
LT - Lituania 6
PY - Paraguay 6
TN - Tunisia 6
DZ - Algeria 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
HR - Croazia 4
KH - Cambogia 4
LB - Libano 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IR - Iran 3
LU - Lussemburgo 3
LV - Lettonia 3
RO - Romania 3
BS - Bahamas 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
PE - Perù 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
GF - Guiana Francese 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
Totale 13.643
Salva come PNG Salva come JPEG
Città #
Singapore 1.180
Ashburn 545
Hefei 493
Hong Kong 395
Fairfield 359
Ho Chi Minh City 307
Southend 300
Chandler 289
Hanoi 276
Bologna 264
San Jose 245
Dallas 226
Seoul 222
Dong Ket 187
Woodbridge 173
Seattle 156
Houston 148
Beijing 134
Cambridge 131
Wilmington 131
Council Bluffs 122
Santa Clara 119
Dublin 112
Princeton 104
Redmond 96
Ann Arbor 95
Boardman 88
Los Angeles 83
Lauterbourg 82
Tokyo 80
Turin 79
Helsinki 61
Milan 57
Bengaluru 52
Redondo Beach 52
New York 50
Frankfurt am Main 46
Lappeenranta 45
Abidjan 43
Berlin 43
Florence 43
Haiphong 43
Sofia 40
Da Nang 38
Jakarta 37
Chicago 34
Westminster 34
Imola 31
Amman 29
Nanjing 28
Nuremberg 27
Buffalo 26
Rome 25
Guangzhou 24
São Paulo 23
Jinan 22
Amsterdam 21
Boydton 20
Can Tho 20
Padova 20
Copenhagen 18
London 18
Shanghai 17
Biên Hòa 16
Hải Dương 16
Mexico City 16
Montreal 16
Phoenix 16
San Diego 16
Vienna 16
Falkenstein 15
Changsha 14
Tianjin 14
Brussels 13
Des Moines 13
Falls Church 13
Istanbul 13
Shenyang 13
Tongling 13
Verona 13
Warsaw 13
Toronto 12
Forlì 11
Munich 11
Quito 11
Stockholm 11
Genoa 10
Hangzhou 10
Orem 10
San Francisco 10
Thái Bình 10
Thái Nguyên 10
Xi'an 10
Yubileyny 10
Atlanta 9
Baghdad 9
Bangkok 9
Bergamo 9
Bình Phước 9
Bắc Giang 9
Totale 8.757
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 408
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 271
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 262
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 241
Chronobiology, sleep-related risk factors and light therapy in perinatal depression: The "Life-ON" project 234
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 224
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 219
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 213
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 209
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 205
A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome. 198
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 198
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 194
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 192
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 188
Clinical effects of Lewy body pathology in cognitively impaired individuals 187
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 186
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 185
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 181
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 179
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 175
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 171
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 171
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 167
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 167
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 166
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 164
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 162
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 162
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 161
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 160
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 156
Is the Epworth Sleepiness Scale a useful tool for screening excessive daytime sleepiness in commercial drivers? 156
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 154
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 153
Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease 150
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 148
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 148
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 148
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 147
Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases 146
Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study 146
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 145
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 141
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 141
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 141
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 141
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? 140
Depressive Symptoms and Amyloid Pathology 137
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC 135
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies 134
Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at PRNP Codon 129 134
Survival of dialysis patients with restless legs syndrome: A 15-year follow-up study 131
Sleep-readiness signals in insomniacs and good sleepers 130
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 129
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease 128
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies 128
Cognitive effects of Lewy body pathology in clinically unimpaired individuals 127
Influence of chronotype on the incidence and severity of perinatal depression in the "Life-ON" study 126
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease 126
Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy 124
Understanding prion strains: Evidence from studies of the disease forms affecting humans 123
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias 122
Recent advances in the histo-molecular pathology of human prion disease 121
Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies 120
Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type 119
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorder 118
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 118
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease 116
Csf ubiquitin levels are higher in alzheimer’s disease than in frontotemporal dementia and reflect the molecular subtype in prion disease 114
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease 112
On the road for a single and reliable objective assessment of sleepiness. 111
Remitting Tics and Narcolepsy Overlap Associated with Streptococcal Infection: A Case Report 111
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease 110
Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature 104
null 103
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 101
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 101
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease 100
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia 98
null 96
Gerstmann-Straüssler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism 95
Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience 92
The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases 91
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification 85
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis 82
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 81
Technique and Preliminary Analysis of Drug-Induced Sleep Endoscopy With Online Polygraphic Cardiorespiratory Monitoring in Patients With Obstructive Sleep Apnea Syndrome. 79
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder 74
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy 72
Reactive microglia partially envelop viable neurons in prion diseases 70
Perspectives Toward the Development of Quantitative Seed Amplification Assays for α-Synuclein 56
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population 49
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 47
Unsuccessful transmissions of atypical genetic Creutzfeldt-Jakob disease (PRNP p.T183A-129M) in transgenic mice 45
Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival 42
PrP proteinopathies 42
The Phenotypic Spectrum of Sporadic Creutzfeldt‐Jakob Disease Cortical Subtype 38
Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism 37
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants 37
Totale 13.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 0 0 0 0 44 28 343
2021/20221.033 55 35 48 35 113 44 16 120 63 95 212 197
2022/20231.317 117 147 62 130 119 107 54 62 233 48 153 85
2023/2024589 18 66 47 69 56 82 16 71 26 60 49 29
2024/20252.296 102 227 172 129 222 123 204 79 61 246 173 558
2025/20266.490 840 821 793 537 736 284 644 221 1.100 514 0 0
Totale 14.044